APP and Alzheimer disease: After the first mutation was discovered in the transmembrane domain of APP in familial AD (FAD)4, several additional pathogenic FAD mutations around the α-, β- or γ-secretase cleavage sites of APP have been identified (alzforum.org/mutations/app), highlighting the importance of the endoproteolytic processing of APP in AD pathogenesis.